德国COVID-19相关的成本和死亡率:从付款人的角度基于发病率的分析
Florian Brandt1, Giancarlo Simone2, Jörg Loth2
1IKK Südwest, Europaallee 3-4, Saarbrücken, 66113, Germany. florian.brandt@ikk-sw.de.
BMC health services research
|March 12, 2024
概括
在德国,COVID-19显著增加了医疗保健成本和死亡率,特别是在老年人中. 后COVID-19综合征进一步提高了这些经济负担和健康影响.
科学领域:
- 卫生经济学 卫生经济学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 估计德国与COVID-19相关的人均医疗保健支出.
- 获得有关COVID-19相关死亡率的见解.
研究的目的:
- 从付款人的角度来看,量化与COVID-19相关的平均医疗保健成本.
- 分析COVID-19对德国死亡率的影响.
主要方法:
- 医疗保险索赔数据的回顾性纵向分析.
- 倾向性得分匹配 (1:1) 将COVID-19患者 (IG) 与对照组 (CG) 进行比较.
- 差异差异 (DiD) 方法用于成本效应估计和Chi-squared测试用于死亡率比较.
主要成果:
- 2021年COVID-19群体的医疗保健费用显著增加 (DiD估计总计1063欧元;COVID-19后综合征患者为3242欧元).
- 在老年人群中,成本的增加更为明显.
- 在COVID-19群体中,死亡率增加了一倍以上,而在60岁及以上的人群中,死亡率增加了三倍.
结论:
- COVID-19与医疗保健成本和死亡率的大幅增加有关,特别是在老年人群中.
- 后COVID-19综合征的发展加剧了医疗保健成本和患者的结果.
更多相关视频
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
2.8K
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
15.1K
相关概念视频
Actuarial Approach
78
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
78
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Kaplan-Meier Approach
137
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
137
Prevalence and Incidence
502
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
502
Introduction To Survival Analysis
235
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
235
Comparing the Survival Analysis of Two or More Groups
186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
